about
Second-generation antidepressants for preventing seasonal affective disorder in adultsBupropion induced serotonin syndrome: a case reportReward-Induced Eating: Therapeutic Approaches to Addressing Food CravingsPsychostimulant treatment of cocaine dependenceEffect of combined naltrexone and bupropion therapy on the brain's reactivity to food cuesNeuroimaging the Effectiveness of Substance Use Disorder Treatments.Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.The effects of opioids and opioid analogs on animal and human endocrine systemsBupropion decreases resting motor threshold: a case report.Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco DependenceAntidepressant-induced liver injury.Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment.Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.Bupropion extended-release for depressive disorders.Naltrexone/Bupropion combination therapy in overweight or obese patients with major depressive disorder: results of a pilot studyEffects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.Nicotinic receptors and stages of nicotine dependence.Classical neurotransmitters and neuropeptides involved in major depression: a review.Analgesic and anti-inflammatory activities of bupropion in animal models.Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort.Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to morning caffeine alone or in combination with carbohydrate.Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis.Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion.Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy.Bupropion effects on high-fat diet-induced steatohepatitis and endothelial dysfunction in rats: role of tumour necrosis factor-alpha.Attention-Deficit/Hyperactivity Disorder.The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats.Effects of bupropion sustained release on task-related EEG alpha activity in smokers: Individual differences in drug response.
P2860
Q24187894-5E1C21D3-4F37-4F67-BA6A-6BD1711B918BQ24631553-3B3FD153-94FB-45EB-9B77-A89196398330Q28074195-FE5B52B3-7A7E-47E2-922E-86A4DD89A48CQ28267550-C71C5BF9-CCEF-44EF-99CF-A3885FBA5CF8Q30438802-24C86D94-E5CA-4B60-9DE5-2A6344632A37Q31096451-AD372A54-8B7E-4C8E-9D1E-82840595BB41Q33449522-E4336CF2-3C7E-4D66-8C01-85AF89B667FBQ33779667-1C7670FD-DC9B-4839-B273-A6BCDAEF7A18Q34001632-23C16113-F6A9-415D-B4AB-365481A83B2BQ34164210-94C4846C-B282-407F-BBEB-8E2A4B56C9ACQ34580845-D23147D4-EA86-4E3C-919D-6B812B42032CQ35057288-9A2725EC-C938-4CFC-9944-21DBCD816A90Q35545542-069ED219-6129-4079-B627-512BDC12472EQ36020455-F3A74A06-C9D2-4632-89D5-A7BB568B0E24Q36406310-A015CCE5-3E4A-421E-A65D-65AC1D8D9C57Q36828445-096A5834-520F-4162-A72D-3CD55E08E0E8Q36885659-A5505C04-7424-4411-955B-FB79D6360445Q36972675-8D8B68A5-02E4-441C-9B75-FBE94C0BE37FQ37035595-95BCD38D-8A17-4E61-BC86-EA1F6C2D4E33Q37154793-4110B1B1-2BE8-41F9-BF59-582C92EF1E4FQ37226997-587EB469-DF36-4A0B-A6B4-594AE054CE10Q37331171-370EA0E2-8894-4363-B6EC-38F2ED0758F7Q37404292-C6452376-6221-4C28-9FFD-590B53187ADAQ37768172-DE471730-ADE3-4159-9FFA-EE520E881212Q41859706-815B7AFA-A5EF-4AC0-A296-BADFAEDEDC06Q42958186-99BC08F2-CFB9-49A2-A40D-E688E413ACC6Q43183967-74F1642B-4284-4F89-B61B-AE9801ECA943Q43239591-7FAE8F10-637D-428E-8F4F-1D1411B16069Q47275311-AB7B415B-3C72-4533-BF82-6258150D5199Q48027985-43F2169C-D194-4E03-AFFE-87EFA1D46D1DQ48044124-C0B24097-E56B-479C-8607-023E881B334BQ48362916-0844E0BE-F585-4A11-83C3-52EA0F051B89Q51805679-0C24276C-39A4-45D6-B09A-77E3C42C2869Q52616964-E8997617-C7D2-471C-8E72-FA61F6BA36E5Q53666291-27D8A3E8-E90D-4399-9E0F-4FF702FF7AF2
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Bupropion: pharmacology and therapeutic applications.
@ast
Bupropion: pharmacology and therapeutic applications.
@en
Bupropion: pharmacology and therapeutic applications.
@nl
type
label
Bupropion: pharmacology and therapeutic applications.
@ast
Bupropion: pharmacology and therapeutic applications.
@en
Bupropion: pharmacology and therapeutic applications.
@nl
prefLabel
Bupropion: pharmacology and therapeutic applications.
@ast
Bupropion: pharmacology and therapeutic applications.
@en
Bupropion: pharmacology and therapeutic applications.
@nl
P2093
P2860
P1476
Bupropion: pharmacology and therapeutic applications.
@en
P2093
Kevin F Foley
Kevin P DeSanty
Richard E Kast
P2860
P304
P356
10.1586/14737175.6.9.1249
P577
2006-09-01T00:00:00Z